<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34986407</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-3511</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>116</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title>
          <ISOAbbreviation>Int J Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>SARS-CoV-2 infection in children in Moscow in 2020: clinical features and impact on circulation of other respiratory viruses: SARS-CoV-2 infection in children in Moscow in 2020.</ArticleTitle>
        <Pagination>
          <StartPage>331</StartPage>
          <EndPage>338</EndPage>
          <MedlinePgn>331-338</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2021.12.358</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1201-9712(21)01216-9</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aimed to estimate the impact of the COVID-19 pandemic on the circulation of non-SARS-CoV-2 respiratory viruses and the clinical characteristics of COVID-19 in hospitalized children.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A total of 226 and 864 children admitted to the Children's City Clinical Hospital with acute respiratory infection in September to November of 2018 and 2020 in Moscow were tested for respiratory viruses using multiplex polymerase chain reaction (PCR) and Mycoplasma pneumoniae/Chlamydia pneumoniae using enzyme-linked immunosorbent assay.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The detection rate of non-SARS-CoV-2 viruses in 2020 was lower than in 2018, 16.9% versus 37.6%. An increase in the median age of children with respiratory viruses was observed during the pandemic (3 years vs 1 year). There was no significant difference in the frequency of intensive care unit (ICU) admission in children with SARS-CoV-2 and other respiratory virus infections (2.7% vs 2.9%). SARS-CoV-2 and human rhinoviruses, human metapneumoviruses, and human adenoviruses showed significantly lower than expected co-detection rates during co-circulation. An increase in body mass index (BMI) or bacterial coinfection leads to an increased risk of ICU admission and a longer duration of COVID-19 in children.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The COVID-19 pandemic led to significant changes in the epidemiological characteristics of non-SARS-CoV-2 respiratory viruses during the autumn peak of the 2020 pandemic, compared with the same period in 2018.</AbstractText>
          <CopyrightInformation>Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yakovlev</LastName>
            <ForeName>Alexander S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia. Electronic address: alex-montreal@yandex.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Belyaletdinova</LastName>
            <ForeName>Ilmira K</ForeName>
            <Initials>IK</Initials>
            <AffiliationInfo>
              <Affiliation>Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia. Electronic address: belyaletdinova_i@mail.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mazankova</LastName>
            <ForeName>Lyudmila N</ForeName>
            <Initials>LN</Initials>
            <AffiliationInfo>
              <Affiliation>Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, 125993, Russia; Z.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, 125373, Russia. Electronic address: mazankova@list.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Samitova</LastName>
            <ForeName>Elmira R</ForeName>
            <Initials>ER</Initials>
            <AffiliationInfo>
              <Affiliation>Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, 125993, Russia; Z.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, 125373, Russia. Electronic address: samitova_rudn@mail.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Osmanov</LastName>
            <ForeName>Ismail M</ForeName>
            <Initials>IM</Initials>
            <AffiliationInfo>
              <Affiliation>Z.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, 125373, Russia. Electronic address: osmanovim@zdrav.mos.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gavelya</LastName>
            <ForeName>Nataly V</ForeName>
            <Initials>NV</Initials>
            <AffiliationInfo>
              <Affiliation>Z.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, 125373, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Volok</LastName>
            <ForeName>Viktor P</ForeName>
            <Initials>VP</Initials>
            <AffiliationInfo>
              <Affiliation>Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Department of Biology, Lomonosov Moscow State University, Moscow, 119991, Russia. Electronic address: viktor.p.v@mail.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kolpakova</LastName>
            <ForeName>Ekaterina S</ForeName>
            <Initials>ES</Initials>
            <AffiliationInfo>
              <Affiliation>Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Institute of Translational Medicine and Biotechnology, Sechenov Moscow State Medical University, Moscow, 119991, Russia. Electronic address: katerina.kolp@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shishova</LastName>
            <ForeName>Anna A</ForeName>
            <Initials>AA</Initials>
            <AffiliationInfo>
              <Affiliation>Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Institute of Translational Medicine and Biotechnology, Sechenov Moscow State Medical University, Moscow, 119991, Russia. Electronic address: a_shishova@list.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dracheva</LastName>
            <ForeName>Natalia A</ForeName>
            <Initials>NA</Initials>
            <AffiliationInfo>
              <Affiliation>Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, 125993, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kozlovskaya</LastName>
            <ForeName>Liubov I</ForeName>
            <Initials>LI</Initials>
            <AffiliationInfo>
              <Affiliation>Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Institute of Translational Medicine and Biotechnology, Sechenov Moscow State Medical University, Moscow, 119991, Russia. Electronic address: lubov_i_k@mail.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karganova</LastName>
            <ForeName>Galina G</ForeName>
            <Initials>GG</Initials>
            <AffiliationInfo>
              <Affiliation>Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Department of Biology, Lomonosov Moscow State University, Moscow, 119991, Russia; Institute of Translational Medicine and Biotechnology, Sechenov Moscow State Medical University, Moscow, 119991, Russia. Electronic address: karganova@bk.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishmukhametov</LastName>
            <ForeName>Aydar A</ForeName>
            <Initials>AA</Initials>
            <AffiliationInfo>
              <Affiliation>Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Institute of Translational Medicine and Biotechnology, Sechenov Moscow State Medical University, Moscow, 119991, Russia. Electronic address: ishmukhametov@chumakovs.su.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Infect Dis</MedlineTA>
        <NlmUniqueID>9610933</NlmUniqueID>
        <ISSNLinking>1201-9712</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000260" MajorTopicYN="Y">Adenoviruses, Human</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009031" MajorTopicYN="N" Type="Geographic">Moscow</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">Children</Keyword>
        <Keyword MajorTopicYN="N">Molecular diagnostics</Keyword>
        <Keyword MajorTopicYN="N">Obesity</Keyword>
        <Keyword MajorTopicYN="N">Respiratory viruses</Keyword>
        <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
      </KeywordList>
      <CoiStatement>Declarations of interest none</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>5</Day>
          <Hour>20</Hour>
          <Minute>7</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34986407</ArticleId>
        <ArticleId IdType="pmc">PMC8720385</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ijid.2021.12.358</ArticleId>
        <ArticleId IdType="pii">S1201-9712(21)01216-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Agrawal B. Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections. Front Immunol. 2019;10 doi: 10.3389/fimmu.2019.02631.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2019.02631</ArticleId>
            <ArticleId IdType="pmc">PMC6856678</ArticleId>
            <ArticleId IdType="pubmed">31781118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ånestad G. Surveillance of respiratory viral infections by rapid immunofluorescence diagnosis, with emphasis on virus interference. Epidemiol Infect. 1987;99:523–531. doi: 10.1017/S0950268800068023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0950268800068023</ArticleId>
            <ArticleId IdType="pmc">PMC2249295</ArticleId>
            <ArticleId IdType="pubmed">2824225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arden KE, Greer RM, Wang CYT, Mackay IM. Genotypic diversity, circulation patterns and co-detections among rhinoviruses in Queensland, 2001. Access Microbiol. 2020;2(e000075) doi: 10.1099/ACMI.0.000075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/ACMI.0.000075</ArticleId>
            <ArticleId IdType="pmc">PMC7525053</ArticleId>
            <ArticleId IdType="pubmed">33062934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>asthma.org.uk. shielding advice high risk 2021. Available at: https://www.asthma.org.uk/advice/triggers/coronavirus-covid-19/shielding-advice-high-risk/. (accessed April 15, 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>Bloom CI, Drake TM, Docherty AB, Lipworth BJ, Johnston SL, Nguyen-Van-Tam JS, et al.  Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 2021;9:699–711. doi: 10.1016/S2213-2600(21)00013-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2213-2600(21)00013-8</ArticleId>
            <ArticleId IdType="pmc">PMC8241313</ArticleId>
            <ArticleId IdType="pubmed">33676593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casalegno JS, Ottmann M, Bouscambert Duchamp M, Escuret V, Billaud G, Frobert E, et al.  Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France. Clin Microbiol Infect. 2010;16:326–329. doi: 10.1111/j.1469-0691.2010.03167.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2010.03167.x</ArticleId>
            <ArticleId IdType="pubmed">20121829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr. 2020;174:882–889. doi: 10.1001/JAMAPEDIATRICS.2020.1467.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/JAMAPEDIATRICS.2020.1467</ArticleId>
            <ArticleId IdType="pubmed">32320004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CDC. People with Moderate to Severe Asthma. Centers Dis Control Prev 2020;19:2019–21. Available at: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/asthma.html (accessed April 24, 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al.  Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study. BMJ. 2020;369 doi: 10.1136/bmj.m1985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId>
            <ArticleId IdType="pmc">PMC7243036</ArticleId>
            <ArticleId IdType="pubmed">32444460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. 2021:131. https://www.rospotrebnadzor.ru/upload/iblock/5fa/gd-seb_02.06-_s-podpisyu_.pdf (accessed November 10, 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>Finney LJ, Glanville N, Farne H, Aniscenko J, Fenwick P, Kemp S.V., et al.  Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon. J Allergy Clin Immunol. 2021;147:510–519. doi: 10.1016/j.jaci.2020.09.034. e5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2020.09.034</ArticleId>
            <ArticleId IdType="pmc">PMC7558236</ArticleId>
            <ArticleId IdType="pubmed">33068560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hartmann-Boyce J, Gunnell J, Drake J, Otunla A, Suklan J, Schofield E, et al.  Asthma and COVID-19: Review of evidence on risks and management considerations. BMJ Evidence-Based Med. 2021;26:195. doi: 10.1136/bmjebm-2020-111506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjebm-2020-111506</ArticleId>
            <ArticleId IdType="pubmed">32883705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joseph C, Togawa Y, Shindo N. Bacterial and viral infections associated with influenza. Influenza Other Respi Viruses. 2013;7:105. doi: 10.1111/IRV.12089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/IRV.12089</ArticleId>
            <ArticleId IdType="pmc">PMC5909385</ArticleId>
            <ArticleId IdType="pubmed">24034494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kompaniyets L, Goodman AB, Belay B, Freedman DS, Sucosky MS, Lange SJ, et al.  Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death — United States, March–December 2020. MMWR Surveill Summ. 2021;70:355–361. doi: 10.15585/mmwr.mm7010e4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15585/mmwr.mm7010e4</ArticleId>
            <ArticleId IdType="pmc">PMC7951819</ArticleId>
            <ArticleId IdType="pubmed">33705371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53:505–512. doi: 10.1016/j.jmii.2020.05.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jmii.2020.05.013</ArticleId>
            <ArticleId IdType="pmc">PMC7245213</ArticleId>
            <ArticleId IdType="pubmed">32482366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81:266–275. doi: 10.1016/j.jinf.2020.05.046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2020.05.046</ArticleId>
            <ArticleId IdType="pmc">PMC7255350</ArticleId>
            <ArticleId IdType="pubmed">32473235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma X, Liu S, Chen L, Zhuang L, Zhang J, Xin Y. The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: A meta-analysis and systematic review. J Med Virol. 2021;93:234–240. doi: 10.1002/jmv.26208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jmv.26208</ArticleId>
            <ArticleId IdType="pmc">PMC7323441</ArticleId>
            <ArticleId IdType="pubmed">32558955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehta NS, Mytton OT, Mullins EWS, Fowler TA, Falconer CL, Murphy OB, et al.  SARS-CoV-2 (COVID-19): What Do We Know about Children? A Systematic Review. Clin Infect Dis. 2020;71:2469–2479. doi: 10.1093/cid/ciaa556.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciaa556</ArticleId>
            <ArticleId IdType="pmc">PMC7239259</ArticleId>
            <ArticleId IdType="pubmed">32392337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meningher T, Hindiyeh M, Regev L, Sherbany H, Mendelson E, Mandelboim M. Relationships between A(H1N1)pdm09 influenza infection and infections with other respiratory viruses. Influenza Other Respi Viruses. 2014;8:422–430. doi: 10.1111/irv.12249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/irv.12249</ArticleId>
            <ArticleId IdType="pmc">PMC4181801</ArticleId>
            <ArticleId IdType="pubmed">24698156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Navarro-Marí JM, Pérez-Ruiz M, JC Galán Montemayor, MÁ Marcos Maeso, Reina J, De Oña Navarro M, et al.  Circulation of other respiratory viruses and viral co-infection during the 2009 pandemic influenza. Enferm Infecc Microbiol Clin. 2012;30:25–31. doi: 10.1016/S0213-005X(12)70101-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0213-005X(12)70101-5</ArticleId>
            <ArticleId IdType="pmc">PMC7130202</ArticleId>
            <ArticleId IdType="pubmed">23116789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nickbakhsh S, Mair C, Matthews L, Reeve R, Johnson PCD, Thorburn F, et al.  Virus–virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci U S A. 2019;116:27142. doi: 10.1073/PNAS.1911083116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/PNAS.1911083116</ArticleId>
            <ArticleId IdType="pmc">PMC6936719</ArticleId>
            <ArticleId IdType="pubmed">31843887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliva A, Siccardi G, Migliarini A, Cancelli F, Carnevalini M, D'Andria M, et al.  Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection. 2020;48:871–877. doi: 10.1007/s15010-020-01483-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s15010-020-01483-8</ArticleId>
            <ArticleId IdType="pmc">PMC7386385</ArticleId>
            <ArticleId IdType="pubmed">32725598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pascalis H, Temmam S, Turpin M, Rollot O, Flahault A, Carrat F, et al.  Intense Co-Circulation of Non-Influenza Respiratory Viruses during the First Wave of Pandemic Influenza pH1N1/2009: A Cohort Study in Reunion Island. PLoS One. 2012;7 doi: 10.1371/JOURNAL.PONE.0044755. e44755.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/JOURNAL.PONE.0044755</ArticleId>
            <ArticleId IdType="pmc">PMC3440351</ArticleId>
            <ArticleId IdType="pubmed">22984554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinky L, Dobrovolny HM. Coinfections of the respiratory tract: Viral competition for resources. PLoS One. 2016;11 doi: 10.1371/journal.pone.0155589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0155589</ArticleId>
            <ArticleId IdType="pmc">PMC4873262</ArticleId>
            <ArticleId IdType="pubmed">27196110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poole S, Brendish NJ, Clark TW. SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study. J Infect. 2020;81:966–972. doi: 10.1016/j.jinf.2020.11.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2020.11.010</ArticleId>
            <ArticleId IdType="pmc">PMC7666810</ArticleId>
            <ArticleId IdType="pubmed">33207254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al.  Bacterial and Fungal Coinfection in Individuals with Coronavirus: A Rapid Review to Support COVID-19 Antimicrobial Prescribing. Clin Infect Dis. 2020;71:2459–2468. doi: 10.1093/cid/ciaa530.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciaa530</ArticleId>
            <ArticleId IdType="pmc">PMC7197596</ArticleId>
            <ArticleId IdType="pubmed">32358954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al.  Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA - J Am Med Assoc. 2020;323:2052–2059. doi: 10.1001/jama.2020.6775.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId>
            <ArticleId IdType="pmc">PMC7177629</ArticleId>
            <ArticleId IdType="pubmed">32320003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarkar S, Khanna P, Singh AK. Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses. J Med Virol. 2021;93:2385–2395. doi: 10.1002/jmv.26740.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jmv.26740</ArticleId>
            <ArticleId IdType="pubmed">33331656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schultz-Cherry S. Viral Interference: The Case of Influenza Viruses. J Infect Dis. 2015;212:1690–1691. doi: 10.1093/infdis/jiv261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiv261</ArticleId>
            <ArticleId IdType="pmc">PMC7107390</ArticleId>
            <ArticleId IdType="pubmed">25943204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al.  High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity. 2020;28:1195–1199. doi: 10.1002/oby.22831.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/oby.22831</ArticleId>
            <ArticleId IdType="pmc">PMC7262326</ArticleId>
            <ArticleId IdType="pubmed">32271993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol. 2020;146:1295–1301. doi: 10.1016/j.jaci.2020.09.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2020.09.017</ArticleId>
            <ArticleId IdType="pmc">PMC7834224</ArticleId>
            <ArticleId IdType="pubmed">33002516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thiberville SD, Ninove L, Hai VV, Botelho-Nevers E, Gazin C, Thirion L, et al.  The viral etiology of an influenza-like illness during the 2009 pandemic. J Med Virol. 2012;84:1071–1079. doi: 10.1002/jmv.23265.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jmv.23265</ArticleId>
            <ArticleId IdType="pmc">PMC7166619</ArticleId>
            <ArticleId IdType="pubmed">22585724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. 2002;2:25–32. doi: 10.1016/S1473-3099(01)00170-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(01)00170-0</ArticleId>
            <ArticleId IdType="pubmed">11892493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al.  Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–436. doi: 10.1038/s41586-020-2521-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId>
            <ArticleId IdType="pmc">PMC7611074</ArticleId>
            <ArticleId IdType="pubmed">32640463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization W. Coronavirus disease 2019 (COVID-2019). Situation Report - 51. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10. World Heal Organ 2020;2019:2633. (accessed April 15, 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization (WHO). WHO body mass index for age bmi for age Available at: https://www.who.int/toolkits/child-growth-standards/standards/body-mass-index-for-age-bmi-for-age. (accessed April 15, 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>Wu A, Mihaylova VT, Landry ML, Foxman EF. Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study. The Lancet Microbe. 2020;1:e254–e262. doi: 10.1016/S2666-5247(20)30114-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2666-5247(20)30114-2</ArticleId>
            <ArticleId IdType="pmc">PMC7580833</ArticleId>
            <ArticleId IdType="pubmed">33103132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yasuhara J, Kuno T, Takagi H, Sumitomo N. Clinical characteristics of COVID-19 in children: A systematic review. Pediatr Pulmonol. 2020;55:2565–2575. doi: 10.1002/ppul.24991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ppul.24991</ArticleId>
            <ArticleId IdType="pubmed">32725955</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
